Market Wrap: 21/03/2017
(19:00)
NSE-NF: 9155 (+1.45
points; +0.02%)
NSE-BNF: 21110 (-73
points; -0.34%)
Vital support for NF:
9105-9035
Vital resistance for
NF: 9195-9275
Vital support for BNF:
21000-20900
Vital resistance for
BNF: 21400-21500
Time & Price action suggests that,
Nifty Fut (March) has to sustain over 9235 area for further rally towards 9275-9350
& 9425-9550 for tomorrow/ in the short term (under bullish case scenario).
On the other side, sustaining below 9215-9195
zone, NF may fall towards 9140-9105 & 9075-9035/8995 area for tomorrow/ in
the short term (under bear case scenario).
Similarly, BNF has to sustain over
21400 area for further rally towards 21500-21675 & 21855-21950 area for
tomorrow/ in the near term (under bullish case scenario).
On the other side, sustaining below
21350-21250 area, BNF may fall towards 21000-20900 & 20800-20600 zone for
tomorrow/ in the near term (under bear case scenario).
Nifty
Fut (March) today closed around 9155 almost flat after a moderate day of volatility
in which it made an opening minutes high of 9172 & subsequent session low
of 9114 and respected the 10-dema (9105 as of now).
The Indian market today
opened in a positive tone following brightening prospect of a July’17 GST
launch after union cabinet yesterday cleared the four GST bill. The sentiment
was further boosted in the morning Asian session after liberal candidate Macron
looked more convincing than the extreme rightist candidate Li-Pen (anti EU) in
a televised election debate in France.
As of now, Macron is leading with around
20% than its prime rival Li-pen, which has also diminished the French election
risk to a great extent and consequently global/EU market sentiment was also
boosted and that helps the Indian market to recover from some loses at the last
hour of trading today.
But,
overall sentiment of the domestic market was somehow tepid today after another
incident of import alert by US FDA on Divis Lab, some product approval issues
with DRL and a product pricing case in USA with Sun Pharma. Overall, going by
the repeated actions by US FDA on Indian Pharma companies, analysts are quite
worried about the future prospect which may be uncertain and considering strict
quality control criteria (CGMP) of the US FDA, these Pharma companies may have
to incur substantial cost/capex to improve its standards/protocol, if they want
to do business in USA. At the same time, other foreign drug regulators may also
take similar action like US FDA and thus going ahead, market/investors might
have less confidence on the Pharma sectors as their earnings may be severely
affected.
Another
area of concern is Indian banking space, specially the PSBS and some old
private banks (ICICI, Axis). Apart from the ongoing concern about farm loan
waiver rhetoric by BJP in UP, analysts are also worried about their tepid loan
growth, which in turn may affect earnings adversely in the coming quarters.
Also, other new generation private banks like Indusind, Yes, Kotak may not be
able to grow at perpetual 25-30% CAGR years after years and there may be
stagnation in the face of growing competition and lack of sufficient eligible
& quality retail borrowers.
Yes
bank was also down today by around 2% after market buzz of its QIP at steep
discounted price for around 1350/-, which was previously cancelled last year
after some controversy (poor response?); although the banks has denied today
any decision regarding its QIP. After big merger between different SBI groups
with its parent (SBI), various private banks may be also exploring some idea about
M&A like in telecom spaces and Kotak bank may be in the forefront.
Idea
was again down today to 93 after yesterday’s epic fall from around 123 as
confusion regarding intrinsic valuation of the merged entity with Vodafone is
going on. As par some analysts, ideal valuation may be somewhere between 90-110,
and as par the merger math with Vodafone, it may be around 72; thus investors
are quite confused considering the stock’s consolidated EPS (Q3FY17 TTM) of
around 1.40 and an industry (telecom) average PE of 20; even considering the
future bright prospect (?) of the merged entity and an expanding PE of 40 &
an EPS of 1.50-1.60 by FY:18-19, fair valuation might be around 62; in FY-17,
it may report an EPS of around 0.05 as par present trend.
Overall,
merger between Idea & Vodafone might be an obligation to counter R-Jio’s
deep pocket and aggressiveness, but it may take significant time till FY-19 for
the actual merger and operational synchronization and its effect on the
earnings. Vodafone may be making a backdoor entry with Idea for its listing in
India, but considering Vodafone’s conservative marketing policy and inertia,
even the combined entity may not pose any serious problem for R-Jio or to even
Bharti Airtel, unless Vodafone changed its marketing policy. Also lack of sufficient
4G spectrum may be another headwind for this merged entity.
Indian
market today was pre-occupied the D-Mart IPO listing which scored a maiden
century on its D-day itself, gaining by more than 117% at around 650/- against
IPO price of 299/-. But, analysts are quite worried about the valuation, which
may be highly expensive at an projected FY-17 EPS of around 8.35, which is
translating of a PE around 78 at today’s high of around 650/-.
Projected
FY-18 EPS of D-Mart may be around 11.20 and at 650, projected FY-18 PE may be
also stretched at around 58. But, the company may be also an exception in the
organized retail format, which is growing around 35-40% CAGR for the last few
years, whereas Future retail with an EPS of 7.12 is commanding a PE of around
35 (industry PE of around 40). Considering saturation in growth and
conservative management & the euphoric investor sentiment, a median PE of
50 may be appropriate for D-Mart as of now and in that scenario, a median valuation
of around 417-560 (8.35*50 & 11.20*50) may be ideal for D-Mart in the
coming days (Projected For FY: 17-18 at consensus EPS).
The euphoric sentient about D-Mart IPO
may be also an indication of the extreme greed level of the Indian market
currently which may be another sign that market may be topping out and
technically also, the corrective 4th wave may have started in the EW
cycle, provided Nifty sustained below 9275 in the coming days; otherwise the
expansive current 3rd wave may further extend towards 9505 zone.
As reflation trade theme is gradually diminishing
in US/global markets amid fall in USD and uncertainty over Trumponomics &
supply glut/fall in Oil, probability of an impending time & price
correction of the Indian market may be more from here.
SGX-NF
BNF
No comments:
Post a Comment